• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1%  SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1%  SODIUM HYALURONATE Back to Search Results
Catalog Number 6301182010
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Fall (1848); Balance Problems (4401); Limb Fracture (4518)
Event Type  Injury  
Event Description
Lost balance [balance disorder].Had fallen and broken her arm [fall].Had fallen and broken her arm [upper limb fracture].Case narrative: case (b)(4) is a serious spontaneous case received from a non-health professional via regulatory authority in united states.This report concerns a female of an unknown age who had lost balance, had fallen and broken her arm during treatment with intra-articular euflexxa (sodium hyaluronate) solution for injection 10 mg, unknown dose, route and frequency, for an unknown indication from an unknown start date to an unknown stop date.The patient had lost balance, had fallen and broken her arm.The patient was hospitalized on an unknown date due to lost balance, had fallen and broken her arm.Action taken with euflexxa was unknown.At the time of this report, the outcome of lost balance, had fallen and broken her arm was unknown no concomitant medication was reported.All events in the case were reported as serious.At the time of reporting the case outcome was unknown.Ferring's sender comment: association of euflexxa to lost balance, fall, and broken her arm events are considered unrelated due to lack of biological plausibility.Overall listedness (core label) is unlisted.Reporter causality: related.Company causality: not related.Other case numbers: internal # - others = mw5092963.This ae occurred in the us and concerns the medical device euflexxa.Please report to your local health authority if required by local law.This ae is not reportable in eu because it did not occur in a eu + efta country and did not result in a corrective action by the manufacturer no corrective action was done by the manufacturer or requested by regulators.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
1%  SODIUM HYALURONATE
Manufacturer (Section D)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
pob 571, be'er tuvia industria
l zone
kiryat malachi 83104 02
IS  8310402
MDR Report Key16439003
MDR Text Key310228729
Report Number0002244564-2020-00006
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 02/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number6301182010
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Event Location Other
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/24/2023
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient SexFemale
-
-